NIH Reporter #5P01DA009158-24

Research Services for Cannabinoid Receptor Probe Pharmacology (CB1/CB2)

This opportunity is issued by the National Institute on Drug Abuse (NIDA), under the U.S. Department of Health and Human Services, for research services related to cannabinoid receptor probes. - Government Buyer: - National Institute on Drug Abuse (NIDA), U.S. Department of Health and Human Services - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Products/Services Requested: - Research services focused on the molecular pharmacology of cannabinoid receptor probes (CB1 and CB2) - No specific products, part numbers, or purchase quantities are listed - Unique or Notable Requirements: - Emphasis on elucidating the in vivo pharmacology of functionally selective CB1 and CB2 probes - Goal is to advance cannabinoid-based therapeutics and facilitate clinical translation - Solicitation classified under biological research and research and development in the physical, engineering, and life sciences - Estimated contract value: $148,280

Description

This project aims to elucidate the in vivo pharmacology of functionally selective CB1 and CB2 probes to improve cannabinoid-based therapeutics and facilitate clinical translation. The research focuses on cannabinoid receptor probes under the National Institute on Drug Abuse (NIDA). The solicitation involves biological research and research and development in the physical, engineering, and life sciences. The estimated contract value is $148,280.

View original listing